查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2045698

膽道支架市場機會、成長要素、產業趨勢分析及2026-2035年預測。

Biliary Stents Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 136 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球膽管支架市場價值為 4.923 億美元，預計到 2035 年將以 6.3% 的複合年成長率成長至 9.164 億美元。

膽道支架市場-IMG1

由於膽道疾病發生率上升、肝胰臟癌盛行率增加以及微創治療方法需求日益成長，膽道支架市場正經歷穩定成長。膽道支架廣泛用於治療膽管阻塞，並支持膽管狹窄、膽漏以及與肝臟和胰臟疾病相關的發炎性疾病患者的有效膽汁排放。先進介入治療技術的日益普及，以及支架技術和影像系統的不斷改進，正在推動全球市場成長。醫療基礎設施的擴建和胃腸道疾病專科治療的普及進一步促進了已開發國家和新興國家對膽道支架的採用。此外，人口老化和生活方式改變導致的慢性疾病負擔加重，也持續推動先進膽道管理解決方案的需求。支架材料、柔軟性、耐用性和留置技術的進步也在改善治療效果，並支持市場的長期發展。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 4.923億美元
預測金額 9.164億美元
複合年成長率 6.3%

隨著醫療專業人員擴大採用微創手術治療膽道併發症，膽道支架市場持續擴張。 ERCP 和 PTC 等技術因其能夠縮短恢復時間、降低手術風險並改善患者預後而日益受到青睞。胰臟癌、肝病、膽道感染疾病和慢性發炎性疾病的日益普遍，顯著增加了對有效支架置入術的需求。惡性及良性疾病引起的膽道阻塞通常需要長期引流治療，這進一步推動了產品需求。此外，支架設計的改進，例如更高的柔軟性、防移位特性和更佳的生物相容性，也促進了其在臨床實踐中的應用。醫療保健支出的成長和先進胃腸病學服務的普及也為該行業創造了有利的成長機會。

預計到2025年，金屬支架市佔率將達到67.8%。金屬支架憑藉其卓越的徑向支撐力、長期耐用性和低阻塞風險，持續保持主導地位。自膨式金屬支架因其能夠延長膽管通暢時間並減少再次手術的需求，在惡性膽道阻塞的治療中越來越受歡迎。膽管癌和胰臟癌發病率的不斷上升，進一步加速了這些先進支架解決方案在安寧療護和長期疾病管理中的應用。

預計到2025年，膽結石市場將佔據52.1%的市場佔有率，並在2026年至2035年間達到4.758億美元。膽結石相關併發症的日益增加是全球膽道支架需求成長的主要原因。不健康的飲食習慣、肥胖和久坐的生活方式等因素正在增加膽結石的形成及其相關的膽道阻塞的發生率。內視鏡支架置入治療方法在恢復膽汁流動、緩解症狀以及最大程度地減少膽道阻塞和發炎性疾病相關併發症仍然發揮著至關重要的作用。

預計到2025年，北美膽道支架市佔率將達到35%。該地區膽道疾病、胰臟疾病和肝膽癌的高發生率使其成為該行業成長的主要貢獻者。肥胖症、代謝紊亂和老齡化相關健康併發症的日益增多，推動了全部區域對先進膽道治療技術的需求不斷成長。北美也受惠於高度發展的醫療保健體系、對先進介入技術的積極應用以及廣泛的專業內視鏡檢查服務。對醫療創新和先進胃腸病學服務的投資不斷增加，也持續推動該地區市場的擴張。

目錄

第1章：調查方法

第2章執行摘要

第3章 行業洞察

  • 產業生態系分析
  • 影響產業的因素
    • 促進因素
      • 膽道疾病和慢性肝病的盛行率增加
      • 微創手術的廣泛應用
      • 支架設計方面的技術進步
      • 擴大內視鏡腔內支架置入術。
    • 產業潛在風險與挑戰
      • 支架及相關手術高成本
      • 膽管支架相關併發症與風險
    • 市場機遇
      • 可生物分解及藥物釋放型支架的研發
      • 進入新興市場
  • 成長潛力分析
  • 監理情勢
  • 技術展望
    • 最新科技趨勢
    • 新興技術
  • 價格分析
  • 未來市場趨勢
  • 波特的分析
  • PESTLE分析
  • 人工智慧和生成式人工智慧對市場的影響
  • 價值鏈分析
  • 投資與資金籌措分析
  • 消費者洞察
  • 治療基礎設施和臨床實施的現狀
  • 差距分析

第4章 競爭情勢

  • 介紹
  • 企業矩陣分析
  • 企業市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
  • 競爭定位矩陣
  • 主要市場公司的競爭分析
  • 主要進展
    • 併購
    • 夥伴關係和聯盟
    • 新產品發布
    • 業務拓展計劃

第5章 市場估計與預測：依類型分類，2022-2035年

  • 金屬支架
  • 聚合物支架

第6章 市場估計與預測：依應用領域分類，2022-2035年

  • 膽結石
  • 胰臟癌
  • 膽汁和胰液滲漏
  • 良性膽道狹窄
  • 其他用途

第7章 市場估計與預測：依最終用途分類，2022-2035年

  • 醫院
  • 門診手術中心
  • 其他最終用戶

第8章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE

第9章：公司簡介

  • Allium Medical
  • Becton, Dickinson and Company
  • Boston Scientific
  • CONMED
  • Cook Medical
  • Cordis
  • ELLA-CS
  • ENDO-FLEX
  • MI Tech
  • Medtronic
  • Merit Medical Systems
  • MICRO-TECH
  • OLYMPUS
  • S&G Biotech
  • Taewoong Medical
簡介目錄
Product Code: 4034

The Global Biliary Stents Market was valued at USD 492.3 million in 2025 and is estimated to grow at a CAGR of 6.3% to reach USD 916.4 million by 2035.

Biliary Stents Market - IMG1

The market is witnessing steady expansion due to the growing occurrence of biliary tract disorders, rising incidence of hepatopancreatic cancers, and increasing preference for minimally invasive treatment procedures. Biliary stents are widely used to manage bile duct blockages and support effective bile drainage in patients suffering from biliary strictures, leaks, and inflammatory conditions linked to liver and pancreatic diseases. The growing use of advanced interventional procedures, combined with ongoing improvements in stent technology and diagnostic imaging systems, is strengthening market growth worldwide. Expanding healthcare infrastructure and rising access to specialized gastroenterology treatments are further supporting adoption across both developed and emerging economies. In addition, the increasing burden of chronic diseases associated with aging populations and changing lifestyle patterns continues to elevate demand for advanced biliary management solutions. Technological progress in stent materials, flexibility, durability, and placement techniques is also improving treatment outcomes and supporting long-term market development.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$492.3 Million
Forecast Value$916.4 Million
CAGR6.3%

The biliary stents market continues to expand as healthcare providers increasingly adopt minimally invasive procedures for the treatment of bile duct complications. Techniques such as ERCP and PTC have become widely preferred due to their ability to reduce recovery time, minimize surgical risks, and improve patient outcomes. The growing prevalence of pancreatic cancer, liver disorders, biliary infections, and chronic inflammatory conditions is significantly increasing the need for effective stenting procedures. Biliary obstruction caused by malignant and benign conditions frequently requires long-term drainage management, further strengthening product demand. In addition, improvements in stent design, including enhanced flexibility, anti-migration features, and better biocompatibility, are contributing to greater clinical adoption. Rising healthcare spending and broader availability of advanced gastroenterology services are also creating favorable growth opportunities for the industry.

The metal stents segment accounted for 67.8% share in 2025. The segment continues to maintain a leading position due to the superior radial strength, long-term durability, and lower risk of blockage associated with metal-based stents. Self-expandable metal stents are increasingly preferred for managing malignant biliary obstructions because they provide prolonged duct patency and reduce the need for repeated interventions. The growing incidence of bile duct cancers and pancreatic malignancies is further accelerating the adoption of these advanced stenting solutions in palliative care and long-term disease management.

The gallstones segment held a share of 52.1% in 2025 and is anticipated to reach USD 475.8 million during 2026-2035. The rising prevalence of gallstone-related complications is significantly contributing to the demand for biliary stents globally. Factors, including unhealthy dietary habits, obesity, and sedentary lifestyles, are increasing the occurrence of gallstone formation and associated biliary obstructions. Endoscopic treatment approaches involving stent placement continue to play an essential role in restoring bile flow, relieving symptoms, and minimizing complications linked to biliary blockages and inflammatory conditions.

North America Biliary Stents Market held a 35% share in 2025. The region remains a major contributor to industry growth due to the high prevalence of biliary diseases, pancreatic disorders, and hepatobiliary cancers. Increasing rates of obesity, metabolic disorders, and age-related health complications are supporting the rising demand for advanced biliary treatment procedures across the region. North America also benefits from a highly developed healthcare system, strong adoption of advanced interventional technologies, and widespread availability of specialized endoscopic procedures. Growing investments in healthcare innovation and advanced gastroenterology services continue to strengthen regional market expansion.

Prominent companies operating in the Global Biliary Stents Industry include Allium Medical, Becton, Dickinson and Company, Boston Scientific, CONMED, Cook Medical, Cordis, ELLA - CS, ENDO-FLEX, M.I Tech, Medtronic, Merit Medical Systems, MICRO-TECH, OLYMPUS, S&G Biotech, and Taewoong Medical. Companies operating in the biliary stents market are focusing on product innovation, strategic collaborations, and expansion of minimally invasive treatment portfolios to strengthen their market presence. Leading manufacturers are investing heavily in research and development activities to improve stent flexibility, durability, biocompatibility, and anti-migration capabilities. Many organizations are also introducing advanced self-expandable metal stents designed to improve long-term drainage performance and reduce procedure-related complications. In addition, companies are expanding partnerships with hospitals, gastroenterology centers, and healthcare providers to increase product accessibility and strengthen distribution networks. Geographic expansion into emerging healthcare markets, combined with rising investments in training programs for interventional procedures, is further supporting business growth.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Type trends
    • 2.2.3 Application trends
    • 2.2.4 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of biliary disorders and chronic liver diseases
      • 3.2.1.2 Growing adoption of minimally invasive procedures
      • 3.2.1.3 Technological advancements in stent design
      • 3.2.1.4 Expanding clinical applications of endoscopic luminal stenting
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of stents and associated procedures
      • 3.2.2.2 Complications and risks related to bile duct stents
    • 3.2.3 Market opportunities
      • 3.2.3.1 Development of biodegradable and drug-eluting stents
      • 3.2.3.2 Expansion in emerging markets
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape (Driven by primary research)
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 MEA
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Pricing analysis (Driven by primary research)
  • 3.7 Future market trends
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Impact of AI and Generative AI on the market (Driven by primary research)
  • 3.11 Value chain analysis (Driven by primary research)
  • 3.12 Investment & funding analysis (Driven by primary research)
  • 3.13 Consumer insights (Driven by primary research)
  • 3.14 Treatment infrastructure & clinical adoption landscape
  • 3.15 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis (Driven by primary research)
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Metal stents
  • 5.3 Polymer stents

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Gallstones
  • 6.3 Pancreatic cancer
  • 6.4 Bilio-pancreatic leakages
  • 6.5 Benign biliary strictures
  • 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Allium Medical
  • 9.2 Becton, Dickinson and Company
  • 9.3 Boston Scientific
  • 9.4 CONMED
  • 9.5 Cook Medical
  • 9.6 Cordis
  • 9.7 ELLA - CS
  • 9.8 ENDO-FLEX
  • 9.9 M.I Tech
  • 9.10 Medtronic
  • 9.11 Merit Medical Systems
  • 9.12 MICRO-TECH
  • 9.13 OLYMPUS
  • 9.14 S&G Biotech
  • 9.15 Taewoong Medical